Market revenue in 2023 | USD 28.4 million |
Market revenue in 2030 | USD 37.7 million |
Growth rate | 4.1% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.79% in 2023. Horizon Databook has segmented the UAE implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
CVDs are a leading cause of mortality and morbidity in the UAE. A survey published in Gulf Insider revealed that over half of the UAE had experienced heart disease, with 12% of the UAE population reporting the illness and 53% having a close friend or relative affected by it.
This high burden of CVDs among the population is expected to drive the demand for cardiovascular devices, including ICDs, contributing to market growth. Several risk factors associated with CVDs were identified in a study conducted among UAE residents, including a sedentary lifestyle, frequent fast & fried food consumption, and poor cardiovascular health practices.
These risk factors contribute to the high incidence of CVDs in the UAE. The UAE has the second highest cardiovascular mortality rate among Gulf Cooperation Council (GCC) countries. The sedentary lifestyle prevalent in the population further adds to the burden of cardiovascular diseases.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into UAE implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account